Crystal Structures of Hydrofumarate Salts of DMT Analogues EPT and MALT Solved
The researchers hope these compounds “will expand the universe of options for improving mental health.”
Scientific Research - Page 16
The Growing Evidence for Psilocybin-Facilitated Smoking Cessation
Comments from Matthew Johnson of Johns Hopkins provide an update on this research.
LSD and Psilocybin May Alleviate Cluster Headaches
Three clinical trials are underway to find out if these psychedelic compounds can provide relief for patients.
Study Finds Aeruginascin Metabolite 4-HO-TMT is Active at the Serotonin 5-HT2A Receptor
Surprisingly, 4-HO-TMT has binding affinity similar to psilocin at 5-HT2A.
Using Zebrafish as an Experimental Model in Psychedelic Research
These creatures have more in common with humans than one might suspect.
Psilocybin to Treat Anxiety and Depression in Cancer Patients
Psychedelic Science Review Editor Barb Bauer conducts a review of some landmark studies.
UNC to Receive $26.9M from DARPA to Develop Psychiatric Medicines
The research will use cutting-edge technology to attempt to remove undesirable side-effects from drugs targeting GPCRs, including the serotonin receptors where psychedelics act.
Solved: The Crystal Structure of N-Methyl-N-Propyltryptamine (MPT)
This structural analog of DMT is an understudied compound presenting new options for psychedelic drug development.
Psychedelics May Relieve Chronic Pain Via Changes in Brain Neuroplasticity
Using psychedelics to treat chronic pain is understudied yet full of potential.
MDMA for PTSD Showing Promising Outcomes for Patients in MAPS Phase 3 Trials
“In the pharmaceutical drug development community, this is what you dream about.”